- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA CAR T-Cell Therapy market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA CAR T-Cell Therapy market. Detailed analysis of key players, along with key growth strategies adopted by CAR T-Cell Therapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Juno Therapeutics (US)
CARsgen Therapeutics (China)
Legend Biotech (US)
Autolus Therapeutics PLC (UK)
Mustang Bio (US)
Pfizer, Inc (US)
Novartis AG (Switzerland)
Sorrento Therapeutics (US)
Cellectis (France)
Kite Pharma (US)
By Type:
Allogeneic
Autologous
By End-User:
Hospitals
Cancer Research Centers
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of CAR T-Cell Therapy Market
-
1.3 Market Segment by Type
-
1.3.1 USA CAR T-Cell Therapy Market Size and Growth Rate of Allogeneic from 2016 to 2027
-
1.3.2 USA CAR T-Cell Therapy Market Size and Growth Rate of Autologous from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA CAR T-Cell Therapy Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 USA CAR T-Cell Therapy Market Size and Growth Rate of Cancer Research Centers from 2016 to 2027
-
1.4.3 USA CAR T-Cell Therapy Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of CAR T-Cell Therapy Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of CAR T-Cell Therapy by Major Types
-
3.4.1 Market Size and Growth Rate of Allogeneic
-
3.4.2 Market Size and Growth Rate of Autologous
4 Segmentation of CAR T-Cell Therapy Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of CAR T-Cell Therapy by Major End-Users
-
4.4.1 Market Size and Growth Rate of CAR T-Cell Therapy in Hospitals
-
4.4.2 Market Size and Growth Rate of CAR T-Cell Therapy in Cancer Research Centers
-
4.4.3 Market Size and Growth Rate of CAR T-Cell Therapy in Others
5 Market Analysis by Regions
-
5.1 USA CAR T-Cell Therapy Production Analysis by Regions
-
5.2 USA CAR T-Cell Therapy Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA CAR T-Cell Therapy Landscape Analysis
-
6.1 West USA CAR T-Cell Therapy Landscape Analysis by Major Types
-
6.2 West USA CAR T-Cell Therapy Landscape Analysis by Major End-Users
7 South USA CAR T-Cell Therapy Landscape Analysis
-
7.1 South USA CAR T-Cell Therapy Landscape Analysis by Major Types
-
7.2 South USA CAR T-Cell Therapy Landscape Analysis by Major End-Users
8 Middle West USA CAR T-Cell Therapy Landscape Analysis
-
8.1 Middle West USA CAR T-Cell Therapy Landscape Analysis by Major Types
-
8.2 Middle West USA CAR T-Cell Therapy Landscape Analysis by Major End-Users
9 Northeast USA CAR T-Cell Therapy Landscape Analysis
-
9.1 Northeast USA CAR T-Cell Therapy Landscape Analysis by Major Types
-
9.2 Northeast USA CAR T-Cell Therapy Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Juno Therapeutics (US)
-
10.1.1 Juno Therapeutics (US) Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 CARsgen Therapeutics (China)
-
10.2.1 CARsgen Therapeutics (China) Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Legend Biotech (US)
-
10.3.1 Legend Biotech (US) Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Autolus Therapeutics PLC (UK)
-
10.4.1 Autolus Therapeutics PLC (UK) Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Mustang Bio (US)
-
10.5.1 Mustang Bio (US) Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Pfizer, Inc (US)
-
10.6.1 Pfizer, Inc (US) Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Novartis AG (Switzerland)
-
10.7.1 Novartis AG (Switzerland) Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Sorrento Therapeutics (US)
-
10.8.1 Sorrento Therapeutics (US) Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Cellectis (France)
-
10.9.1 Cellectis (France) Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Kite Pharma (US)
-
10.10.1 Kite Pharma (US) Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA CAR T-Cell Therapy Market Size and Growth Rate of Allogeneic from 2016 to 2027
-
Figure USA CAR T-Cell Therapy Market Size and Growth Rate of Autologous from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA CAR T-Cell Therapy Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure USA CAR T-Cell Therapy Market Size and Growth Rate of Cancer Research Centers from 2016 to 2027
-
Figure USA CAR T-Cell Therapy Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of CAR T-Cell Therapy Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of CAR T-Cell Therapy
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of CAR T-Cell Therapy by Different Types from 2016 to 2027
-
Table Consumption Share of CAR T-Cell Therapy by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Allogeneic
-
Figure Market Size and Growth Rate of Autologous
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of CAR T-Cell Therapy by Different End-Users from 2016 to 2027
-
Table Consumption Share of CAR T-Cell Therapy by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Cancer Research Centers
-
Figure Market Size and Growth Rate of Others
-
Table USA CAR T-Cell Therapy Production by Regions
-
Table USA CAR T-Cell Therapy Production Share by Regions
-
Figure USA CAR T-Cell Therapy Production Share by Regions in 2016
-
Figure USA CAR T-Cell Therapy Production Share by Regions in 2021
-
Figure USA CAR T-Cell Therapy Production Share by Regions in 2027
-
Table USA CAR T-Cell Therapy Consumption by Regions
-
Table USA CAR T-Cell Therapy Consumption Share by Regions
-
Figure USA CAR T-Cell Therapy Consumption Share by Regions in 2016
-
Figure USA CAR T-Cell Therapy Consumption Share by Regions in 2021
-
Figure USA CAR T-Cell Therapy Consumption Share by Regions in 2027
-
Table West USA CAR T-Cell Therapy Consumption by Types from 2016 to 2027
-
Table West USA CAR T-Cell Therapy Consumption Share by Types from 2016 to 2027
-
Figure West USA CAR T-Cell Therapy Consumption Share by Types in 2016
-
Figure West USA CAR T-Cell Therapy Consumption Share by Types in 2021
-
Figure West USA CAR T-Cell Therapy Consumption Share by Types in 2027
-
Table West USA CAR T-Cell Therapy Consumption by End-Users from 2016 to 2027
-
Table West USA CAR T-Cell Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure West USA CAR T-Cell Therapy Consumption Share by End-Users in 2016
-
Figure West USA CAR T-Cell Therapy Consumption Share by End-Users in 2021
-
Figure West USA CAR T-Cell Therapy Consumption Share by End-Users in 2027
-
Table South USA CAR T-Cell Therapy Consumption by Types from 2016 to 2027
-
Table South USA CAR T-Cell Therapy Consumption Share by Types from 2016 to 2027
-
Figure South USA CAR T-Cell Therapy Consumption Share by Types in 2016
-
Figure South USA CAR T-Cell Therapy Consumption Share by Types in 2021
-
Figure South USA CAR T-Cell Therapy Consumption Share by Types in 2027
-
Table South USA CAR T-Cell Therapy Consumption by End-Users from 2016 to 2027
-
Table South USA CAR T-Cell Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure South USA CAR T-Cell Therapy Consumption Share by End-Users in 2016
-
Figure South USA CAR T-Cell Therapy Consumption Share by End-Users in 2021
-
Figure South USA CAR T-Cell Therapy Consumption Share by End-Users in 2027
-
Table Middle West USA CAR T-Cell Therapy Consumption by Types from 2016 to 2027
-
Table Middle West USA CAR T-Cell Therapy Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA CAR T-Cell Therapy Consumption Share by Types in 2016
-
Figure Middle West USA CAR T-Cell Therapy Consumption Share by Types in 2021
-
Figure Middle West USA CAR T-Cell Therapy Consumption Share by Types in 2027
-
Table Middle West USA CAR T-Cell Therapy Consumption by End-Users from 2016 to 2027
-
Table Middle West USA CAR T-Cell Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA CAR T-Cell Therapy Consumption Share by End-Users in 2016
-
Figure Middle West USA CAR T-Cell Therapy Consumption Share by End-Users in 2021
-
Figure Middle West USA CAR T-Cell Therapy Consumption Share by End-Users in 2027
-
Table Northeast USA CAR T-Cell Therapy Consumption by Types from 2016 to 2027
-
Table Northeast USA CAR T-Cell Therapy Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA CAR T-Cell Therapy Consumption Share by Types in 2016
-
Figure Northeast USA CAR T-Cell Therapy Consumption Share by Types in 2021
-
Figure Northeast USA CAR T-Cell Therapy Consumption Share by Types in 2027
-
Table Northeast USA CAR T-Cell Therapy Consumption by End-Users from 2016 to 2027
-
Table Northeast USA CAR T-Cell Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA CAR T-Cell Therapy Consumption Share by End-Users in 2016
-
Figure Northeast USA CAR T-Cell Therapy Consumption Share by End-Users in 2021
-
Figure Northeast USA CAR T-Cell Therapy Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Juno Therapeutics (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Juno Therapeutics (US)
-
Figure Sales and Growth Rate Analysis of Juno Therapeutics (US)
-
Figure Revenue and Market Share Analysis of Juno Therapeutics (US)
-
Table Product and Service Introduction of Juno Therapeutics (US)
-
Table Company Profile and Development Status of CARsgen Therapeutics (China)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CARsgen Therapeutics (China)
-
Figure Sales and Growth Rate Analysis of CARsgen Therapeutics (China)
-
Figure Revenue and Market Share Analysis of CARsgen Therapeutics (China)
-
Table Product and Service Introduction of CARsgen Therapeutics (China)
-
Table Company Profile and Development Status of Legend Biotech (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Legend Biotech (US)
-
Figure Sales and Growth Rate Analysis of Legend Biotech (US)
-
Figure Revenue and Market Share Analysis of Legend Biotech (US)
-
Table Product and Service Introduction of Legend Biotech (US)
-
Table Company Profile and Development Status of Autolus Therapeutics PLC (UK)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Autolus Therapeutics PLC (UK)
-
Figure Sales and Growth Rate Analysis of Autolus Therapeutics PLC (UK)
-
Figure Revenue and Market Share Analysis of Autolus Therapeutics PLC (UK)
-
Table Product and Service Introduction of Autolus Therapeutics PLC (UK)
-
Table Company Profile and Development Status of Mustang Bio (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mustang Bio (US)
-
Figure Sales and Growth Rate Analysis of Mustang Bio (US)
-
Figure Revenue and Market Share Analysis of Mustang Bio (US)
-
Table Product and Service Introduction of Mustang Bio (US)
-
Table Company Profile and Development Status of Pfizer, Inc (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer, Inc (US)
-
Figure Sales and Growth Rate Analysis of Pfizer, Inc (US)
-
Figure Revenue and Market Share Analysis of Pfizer, Inc (US)
-
Table Product and Service Introduction of Pfizer, Inc (US)
-
Table Company Profile and Development Status of Novartis AG (Switzerland)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG (Switzerland)
-
Figure Sales and Growth Rate Analysis of Novartis AG (Switzerland)
-
Figure Revenue and Market Share Analysis of Novartis AG (Switzerland)
-
Table Product and Service Introduction of Novartis AG (Switzerland)
-
Table Company Profile and Development Status of Sorrento Therapeutics (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sorrento Therapeutics (US)
-
Figure Sales and Growth Rate Analysis of Sorrento Therapeutics (US)
-
Figure Revenue and Market Share Analysis of Sorrento Therapeutics (US)
-
Table Product and Service Introduction of Sorrento Therapeutics (US)
-
Table Company Profile and Development Status of Cellectis (France)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cellectis (France)
-
Figure Sales and Growth Rate Analysis of Cellectis (France)
-
Figure Revenue and Market Share Analysis of Cellectis (France)
-
Table Product and Service Introduction of Cellectis (France)
-
Table Company Profile and Development Status of Kite Pharma (US)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kite Pharma (US)
-
Figure Sales and Growth Rate Analysis of Kite Pharma (US)
-
Figure Revenue and Market Share Analysis of Kite Pharma (US)
-
Table Product and Service Introduction of Kite Pharma (US)
-